Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.00
$0.00
▼
$0.01
$3K5.77,334 shs96,270 shs
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$0.00
$0.00
▼
$0.10
$1K0.796,942 shsN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
$0.00
$0.00
▼
$0.08
$11K7.759,683 shs16,269 shs
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
$0.00
+∞		$0.00
$0.00
▼
$0.00
$1K2.92656 shs752 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%0.00%0.00%-66.67%-80.00%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.00%0.00%0.00%0.00%0.00%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00%0.00%-16.67%-37.50%-97.06%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.00
$0.00
▼
$0.01
$3K5.77,334 shs96,270 shs
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$0.00
$0.00
▼
$0.10
$1K0.796,942 shsN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
$0.00
$0.00
▼
$0.08
$11K7.759,683 shs16,269 shs
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
$0.00
+∞		$0.00
$0.00
▼
$0.00
$1K2.92656 shs752 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%0.00%0.00%-66.67%-80.00%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.00%0.00%0.00%0.00%0.00%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00%0.00%-16.67%-37.50%-97.06%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.00
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00
N/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.00N/AN/A($0.03) per share0.00
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$319K0.00N/AN/A$1.74 per share0.00
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.00N/AN/A($6.91) per share0.00
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
$51.69M0.00N/AN/AN/A∞
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$0.11N/AN/AN/A-272.74%-311.64%-11.57%N/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
-$12.87M-$14.69N/AN/AN/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08M-$3.89N/AN/AN/A-563.16%N/A-174.06%N/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
-$34.11M-$4.21N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
20.06%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
N/A

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.34%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
8.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.91 million28.23 millionNo Data
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
305.77 million5.75 millionNot Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionNo Data
Minerva Surgical, Inc. stock logo
UTRS
Minerva Surgical
1608.88 million8.12 millionNot Optionable

Recent News About These Companies

Interpace Biosciences (OTCMKTS:IDXG) vs. Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931801
Minerva Surgical Inc.
January 10, 2024  |  thestreet.comhttps://www.thestreet.com/quote/UTRS
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
December 18, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/why-is-minerva-surgical-utrs-stock-down-50-today-1032909053
Minerva Surgical Inc UTRS
December 17, 2023  |  morningstar.comM
Minerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial Results
November 14, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-11/60655170-minerva-surgical-inc-minerva-surgical-reports-third-quarter-2023-financial-results-399.htm
Minerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93M
November 14, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/minerva-surgical-gaap-eps-of-081-misses-by-027-revenue-of-12m-misses-by-193m/ar-AA1jUxIF
Minerva Surgical Reports Third Quarter 2023 Financial Results
November 13, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/minerva-surgical-reports-third-quarter-210100017.html?.tsrc=rss
Accelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange Commission
September 29, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/accelmed-files-transaction-statement-schedule-154542133.html
Minerva Surgical Inc (UTRS) Becoming More Attractive for Investors
September 27, 2023  |  knoxdaily.comK
UTRS Shares Experience Surge in Value
August 25, 2023  |  knoxdaily.comK
Minerva Surgical Reports Second Quarter 2023 Financial Results
August 3, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/minerva-surgical-reports-second-quarter-200100964.html?.tsrc=rss
Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates
August 3, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/minerva-surgical-inc-utrs-reports-212516643.html?.tsrc=rss
Investors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past week
May 25, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/investors-minerva-surgical-nasdaq-utrs-100912389.html?.tsrc=rss
Patent Grant Sends Healthcare Shares Soaring Premarket
May 24, 2023  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/indices/INX/pressreleases/17151901/patent-grant-sends-healthcare-shares-soaring-premarket/
Why Minerva Surgical Shares Are Taking Off Wednesday
May 24, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/why-minerva-surgical-shares-are-taking-off-wednesday/ar-AA1bDjLy
Why Is Minerva Surgical (UTRS) Stock Up 229% Today?
May 24, 2023  |  msn.comhttps://www.msn.com/en-us/money/topstocks/why-is-minerva-surgical-utrs-stock-up-229-today/ar-AA1bCRfR
Q1 2023 Minerva Surgical Inc Earnings Call
May 3, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/q1-2023-minerva-surgical-inc-100943414.html?.tsrc=rss
Minerva Surgical Reports First Quarter 2023 Financial Results
May 2, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/minerva-surgical-reports-first-quarter-200100555.html?.tsrc=rss
Modified Minerva orthosis proven helpful in pediatric patients following airway surgery
May 2, 2023  |  medicalxpress.comM
Minerva Surgical to Announce First Quarter 2023 Financial Results
April 18, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/minerva-surgical-announce-first-quarter-200100312.html?.tsrc=rss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0001 0.00 (0.00%)
As of 08/10/2026 02:47 PM Eastern

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Motus GI stock logo

Motus GI NASDAQ:MOTS

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.0005 0.00 (0.00%)
As of 08/10/2026 01:40 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Minerva Surgical stock logo

Minerva Surgical NASDAQ:UTRS

$0.0001 +0.00 (+∞)
As of 08/10/2026 09:41 AM Eastern

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas